U.S. Auto Components Stock News

United Therapeutics reported positive phase 3 results from its TETON-1 study of nebulized Tyvaso in idiopathic pulmonary fibrosis (IPF). The trial met its primary efficacy endpoint and showed significant benefits over placebo with a favorable safety profile. The company plans to seek a supplemental FDA approval to add IPF to the Tyvaso label, supported by integrated data from TETON-1 and TETON-2. For investors watching United Therapeutics, ticker NasdaqGS:UTHR, this news arrives with the...

If you are wondering whether Franklin Resources at around US$22.75 is offering good value or potential overpayment, the recent share price path gives you a useful starting point. The stock has seen a 4.8% decline over the last week and a 14.3% decline over the last month, yet it still shows a 23.1% return over the past year, which can change how investors think about both risk and opportunity. Across the market, investors have been closely watching asset managers as sentiment around capital...

Strategy, traded as NasdaqGS:MSTR, appears to have paused its weekly Bitcoin purchases after a 13 week streak. No recent Bitcoin accumulation has been reported or publicized by Executive Chairman Michael Saylor. The pause breaks an established buying pattern that had become central to the company’s Bitcoin treasury approach. This shift comes alongside recent changes in preferred stock funding used to support prior Bitcoin acquisitions. For readers following NasdaqGS:MSTR, the company is...

Wondering if Atlanta Braves Holdings at around US$41.53 is offering good value or just a fan premium? This breakdown is designed to help you see what the current price really represents. The stock has seen a 1% decline over the last 7 days and a 5% decline over the last 30 days, while still showing returns of 4.2% year to date, 3.8% over 1 year, 23.2% over 3 years and 43.2% over 5 years. Recent coverage has focused on the company as a way to gain exposure to a well known sports franchise...

Why National Bank Holdings is on investors’ radar National Bank Holdings (NBHC) has been drawing attention after a recent period of mixed share performance, with a 1 day decline of 1.6% and a month return of 5.1%. Against that backdrop, investors are weighing the bank’s current valuation against its reported US$398.3m in revenue and US$108.7m in net income, along with multi year total return figures that extend up to the past 5 years. See our latest analysis for National Bank Holdings. At a...

Pinterest recently received a US$1.00 billion investment from affiliates of Elliott Investment Management and used the funds to launch a US$1.00 billion accelerated share repurchase under a broader US$3.50 billion board-approved program, underscoring its focus on capital returns. This move highlights Pinterest’s strong free cash flow profile and signals management’s confidence in the platform’s ability to support shareholder-focused capital allocation. We’ll now examine how this large...

Christopher Hogbin, CEO of Asset Management at Lazard, recently exercised a sizable block of stock options. Following the exercise, he sold a significant portion of common shares, reducing his direct shareholdings. Hogbin still holds a large position in Lazard through outstanding restricted stock units, keeping meaningful exposure to NYSE:LAZ. Lazard, traded on the NYSE under ticker NYSE:LAZ, last closed at $39.11. The share price reflects a 22.7% decline over the past 30 days and a 21.4%...

Wondering if Clearwater Analytics Holdings at around US$23.49 is offering good value right now, or if the price already reflects most of the upside you care about. The stock has been relatively steady in the near term, with a 0.9% return over the last 7 days and 0.4% over the last 30 days, while year to date it shows a 2.6% decline and the 1 year return sits at a 12.4% decline, compared with a 48.6% gain over 3 years. Recent coverage has focused on Clearwater Analytics Holdings as a listed...

Why the new Fiserv partnership matters for Western Alliance Bancorporation (WAL) Western Alliance Bancorporation (WAL) is back in focus after Fiserv announced an agent bank partnership that brings its Clover payments and business management tools directly to Western Alliance Bank’s commercial clients. The arrangement, described by Fiserv as its largest agent bank partnership by asset size, expands Western Alliance’s access to merchant technology for businesses ranging from small firms to...

With no single headline event driving attention today, JBS (NYSE:JBS) is drawing interest as investors look at its recent share moves and its sizeable global meat processing footprint across beef, pork, poultry, and prepared foods. See our latest analysis for JBS. JBS’s recent 7 day share price return of 13.01% and 90 day share price return of 17.53%, with the stock now at $17.03, suggest momentum has picked up after a quieter 30 day share price return of 0.83%. If the JBS move has you...

Hawaiian Electric Industries (NYSE:HE) has agreed to a $100 million settlement to resolve significant stockholder derivative lawsuits. The payment will be funded by insurers and also partially settles a related securities class action. The agreement is subject to final court approval, with upcoming hearings expected to clarify the remaining legal process. For shareholders watching NYSE:HE at a current share price of $14.67, this settlement addresses a key source of legal uncertainty. The...

Curious if Union Pacific at around US$238.79 is offering fair value or a margin of safety right now? This article walks through the key numbers that matter for you. The stock has seen mixed returns recently, with a 0.2% move over the last 7 days, a 9.9% decline over 30 days, gains of 3.0% year to date and 3.5% over the last year, and gains of 28.2% over 3 years and 19.6% over 5 years. Recent coverage of Union Pacific has focused on its role as a major U.S. railroad operator and how broader...

Xcel Energy (NasdaqGS:XEL) has filed new regulatory materials with the Federal Energy Regulatory Commission focused on dam safety and compliance. The company’s recent correspondence covers dam stability, embankment integrity, and landslide monitoring at its hydro-related facilities. These filings outline ongoing safety measures and responses to federal oversight of critical infrastructure. Xcel Energy, a regulated electric and natural gas utility, depends on reliable generation and...

For readers wondering whether Smithfield Foods at US$26.69 still offers value, or if the easy gains are already behind it, this article breaks down what the current price might be implying. The stock has returned 13.7% over the past week, 7.3% over the last month, 20.5% year to date, and 36.9% over the past year, which naturally raises questions about how expectations and risk are now being priced in. Recent coverage around Smithfield Foods has focused on its positioning within the food...

If you are wondering whether Viavi Solutions at US$34.64 is still attractively priced after a big run, the key question is what that price actually reflects about the business. The stock has delivered returns of 3.1% over the past week, 16.6% over the past month, 90.9% year to date and 209.6% over the last year, with a 225.3% return over three years and 114.0% over five years, which puts recent valuation questions front and center. Recent coverage has focused on Viavi Solutions as a...

The Public Service Commission of South Carolina has approved Duke Energy’s plan to build an approximately 1,365 MW high-efficiency natural gas plant in Anderson County, with construction targeted to start in 2027 and operations by early 2031, following an extensive public review and community engagement process. This facility, expected to support more than 2,200 jobs annually during construction and deliver an estimated US$84 million in yearly statewide economic impact once operational, also...

Palvella Therapeutics (NasdaqCM:PVLA) has appointed Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services. McDonough has extensive experience launching and commercializing therapies for rare skin diseases, including work on VYJUVEK®. The appointment is intended to support Palvella’s commercial readiness as QTORIN™ rapamycin advances through late-stage trials. For investors watching rare disease drug developers, Palvella Therapeutics sits at the intersection of...

In the past week, Best Buy reported quarterly results showing adjusted EPS of US$2.61, up 1.2% year over year, alongside a 0.8% decline in comparable sales and slightly softer-than-expected revenue, while also announcing a 1% increase in its quarterly dividend to US$0.96 per share. Management’s decision to raise the dividend and emphasize scalable profit drivers such as its digital Marketplace and Best Buy Ads highlights a focus on recurring, higher-margin revenue streams even as top-line...

In late March 2026, Paychex reported third-quarter revenue of US$1,808.9 million and net income of US$560.3 million, alongside updates on completing two share repurchase authorizations totaling US$400 million and US$352.22 million, and highlighted its cybersecurity focus ahead of an RSA Conference presentation. While revenue and quarterly earnings per share increased year over year, nine-month net income and EPS were slightly lower, underscoring that growth in sales has not yet translated...

If you are wondering whether Cal-Maine Foods at around US$77.12 is pricing in too much optimism or leaving some value on the table, a closer look at its valuation can help frame that question. The share price is near US$77.12 after a 0.1% move over the last 7 days, with an 11.5% decline over 30 days, a 1.7% decline year to date, a 7.8% decline over 1 year, but a 53.8% gain over 3 years and a 159.0% gain over 5 years. Recent coverage has focused on Cal-Maine Foods as a key player in the US...

CDW stock performance context CDW (CDW) has drawn attention after a period where the share price shows a 2.5% decline over the past day and negative returns over the week, month, past 3 months, year to date, and past year. See our latest analysis for CDW. At a share price of $118.17, CDW’s recent 1 day share price decline of 2.5% sits within a broader period of weaker momentum, with a 1 year total shareholder return of 25.0% in the red. This may reflect cooler sentiment around its risk and...

If you are wondering whether lululemon athletica's current share price really reflects what the business is worth, starting with a clear look at valuation can help you frame that question properly. The stock last closed at US$145.85, with returns of an 11.3% decline over 7 days, a 21.2% decline over 30 days, a 30.8% decline year to date, and a 48.5% decline over the past year, which has likely shifted how many investors think about its potential and risk. Recent headlines around lululemon...

For readers wondering whether Indivior Pharmaceuticals at around US$28.97 is still a good entry point or more of a hold after such a big run, this article focuses squarely on what the current valuation is indicating. The stock has pulled back, with a 1.4% decline over the last 7 days, an 11.5% decline over 30 days, and an 18.9% decline year to date. This follows a very strong 204.0% return over 1 year and 216.6% over 5 years. Recent attention around Indivior Pharmaceuticals has centered on...

Over the past year, Agnico Eagle Mines has seen substantial insider selling, including about US$16,000,000 of stock offloaded in the last quarter with no corresponding insider purchases, and the largest single sale coming from CEO Ammar Al-Joundi at a price below where the shares trade today. This pattern of executives reducing their holdings without any offsetting buys may raise questions for investors about how insiders currently view the company’s valuation. Next, we’ll examine how this...